What happened
Osang Healthcare reported consolidated results for FY2025: revenue of US$87.8M (+59.8% year on year), operating profit of US$1.66M (from a loss a year earlier) and net income of US$2.12M (from a loss a year earlier).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$87.8M |
|---|---|
| Revenue vs a year earlier | +59.8% |
| Operating profit | US$1.66M |
| Net income | US$2.12M |
| Period | FY2025 (consolidated) |
| Filed | 2026-03-10, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260310901380 → open original filing |
Source: DART. Information only, not investment advice.